Patent · US Expired

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

US7354992B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 4, 2003
Grant dateApr 8, 2008
Priority date
Expiry dateDec 16, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/4748
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.